| Analysis | Metabolite Name | Measured Value | Units | Source |
|---|---|---|---|---|
| GCMS positive ion mode | butane-2,3-diol NIST | 440.4582945 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 478.7653106 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 485.2083392 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 506.2215138 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 509.9992734 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 544.5619111 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 545.1653437 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 547.7257606 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 560.6299863 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 591.5526478 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 597.0436941 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 606.0497075 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 620.0020168 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 638.7475359 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 640.2366019 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 660.0782191 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 660.4601579 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 664.9492136 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 670.6015023 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 672.348754 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 687.1111349 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 697.4255911 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 713.5079935 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 736.9797991 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 737.9552197 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 744.7744688 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 753.3135836 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 763.2710305 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 764.5497417 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 782.0002042 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 782.8685638 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 792.1264719 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 797.1043867 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 804.9494402 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 805.3220352 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 824.3838812 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 825.3732712 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 831.1761305 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 865.0227036 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 867.9180638 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 890.9866225 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 935.4171778 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 936.7551893 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 963.8041925 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 981.2532377 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 1039.849459 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 1043.522868 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 1069.522522 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 1074.342615 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 1086.207998 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 1141.275474 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 1203.658069 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 1311.159599 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 1510.224078 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 1616.180227 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 2022.425839 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 2428.726502 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 5939.53818 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | butane-2,3-diol NIST | 38732.13632 | Peak area | Group 1 - Human Serum |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|